No Data
No Data
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion in 4 years.
VENUS MEDTECH-B: 2024 INTERIM REPORT
Qiming Medical-B (02500.HK): Zhu Bing appointed as Chief Financial Officer.
Gelonghui, September 9th: Qiming Medical-B (02500.HK) announced that Zhu Bing has been appointed as the company's Chief Financial Officer, effective from September 9, 2024.
Express News | Venus Medtech Hangzhou - Bing Zhu Appointed as CFO
A Quick Understanding: Announcement of Key Findings in the Review of Funds Usage for Qiming Medical-B (02500)
The stock has been suspended from trading on the Main Board of the Stock Exchange of Hong Kong since November 23, 2023. During this period, active communication with the Stock Exchange of Hong Kong has been conducted and a series of measures have been taken to meet the five resumption guidance, in order to resume trading of the company as soon as possible. The latest announcement on September 2 provides further disclosure on the progress of the first item of the five resumption guidance by the Stock Exchange of Hong Kong.
Express News | Venus Medtech Venus-Vitae Completes First Two Implantations in Smart-Align Pivotal Clinical Study
No Data
No Data